Dr. Shannon R. Galvin, MD

Dr. Galvin practices at Northwestern Memorial Hospital in Chicago, Illinois, part of Northwestern Memorial HealthCare.

Dr. Galvin's NPI, 1003862400, was assigned on May 26, 2006. Dr. Galvin graduated from University of Miami, Lm Miller School of Medicine in 1997. Dr. Galvin holds Illinois license 036121851.

Dr. Galvin's primary practice is Northwestern Memorial Hospital, at 251 E Huron St, Chicago, IL 60611 in Cook County. The practice phone is (312) 926-2000.

Dr. Galvin's primary practice is Northwestern Memorial Hospital in Chicago, Illinois, part of Northwestern Memorial HealthCare. The medical group on file is Northwestern Medical Faculty Foundation.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Galvin practices. Vendor and product names are available with a free account.

Infectious disease is Dr. Galvin's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Galvin is licensed in Illinois.

CMS data shows 256 Medicare services from Dr. Galvin across 6 procedure codes in 2024, for 156 Medicare patients. Medicare paid $22,144 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 156 Medicare patients who saw Dr. Galvin in 2024. The largest group is 65 to 74, with 54 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 33% are also on Medicaid. Their average risk score is 3.45, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Galvin's median patient age at 62, with 30% women.

In 2024, Dr. Galvin wrote 505 Medicare Part D claims for 54 patients. 54% of them were for generic drugs. CMS names the drug for 320 of them, across 17 drugs with 11 or more claims each, at $743,572 in total drug cost. In 2023, CMS named 330 claims across 18 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Galvin for performance year 2024, reported through an alternative payment model (APM). Dr. Galvin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Galvin as offering telehealth.

Dmand AI links 21 papers to Dr. Galvin, published from 2011 to 2023. 2020 was the busiest year, with 3. The most frequent topics are HIV Infections, Anti-Bacterial Agents and Chicago. Dr. Galvin has published most often in AIDS Patient Care STDS. Dr. Galvin's most frequent co-authors are Karen M. Krueger, MD, Mary Clare Masters, MD and Maureen K. Bolon, MD.

CMS Open Payments shows 11 general payments to Dr. Galvin from 2 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 99% of the total. Gilead Sciences, Inc. paid the most, $113,172.

Dr. Galvin graduated from University of Miami, Lm Miller School of Medicine in 1997.